Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What if...the rumor from the other day comes true....hopefully at a pleasant/great premium....nice Christmas gift.
I can think of a Common household name....Johnson & Johnson.
Merry Christmas and happy holidays to all!
cg_future
Thanks for the info. Let's see how it goes.
-vg_future
TDAmeritrade is showing 12/23 as the earnings date. Maybe it picked it up from systems out there (could be an estimated/expected date), but I haven't seen any PR from the company about the earnings release yet. Interesting.
-vg_future
Thanks RedShoulder (one more time) for that call to IR and also all the emails (from posters here) regarding SAS to the TGA where they got clarification on the eligibility for the drug usage under SAS. It is as clear as it can get....now a nice earnings PR from Anavex should put an end to the confusion and confirm....one more time....the applicability of SAS rules and access to all the patients. Huge huge potential.
-vg_future
Kevindenver, exactly....none of this matters pretty soon as we keep getting positive read outs.
vg_future
Thanks boi568 for checking. Appreciate it.
-vg_future
tootalljones, this seems like an important one... PDD study - primary and secondary endpoints MET. Did anyone verify and/or confirm this NEWS bit. Anavex should fly on this NEWS...maybe there will be a PR soon.
-vg_future
kevindener, I know. If you read my list, you can see that
- the NEWS about SAS is already announced...revenue reporting can be done in quarterly results once tallied/calculated/audited (no regualation FD rule needs to be applied...normal business)
- PDD readout finalization....they can keep quiet until it is done...no need to regulation FD rules
- Partnership deal...until finalized is not material...
So, what I meant by quiet is company keeping quiet (not necessarily SEC's quiet period definition) while putting things together..
-vg_future
Quiet period (in essence) could also be due any pending NEWS or activity. What is the event or activity impacts the material info? That could cause the delay while the numbers or details are being worked out. My favorite guesses are
- revenue from Australia (SAS)
- finalizing the PDD readout
- partnership and details
.........
vg_future
tootalljones, where is this info coming from..."has stopped its internal sell program half an hour ago "...opinion or fact? TIA
Boi568, couldn’t agree more. This stock is heavily manipulated....particularly when there is some good NEWS. I just wish this time the manipulators get their clocks cleaned...thoroughly.
The science has to get traction (and withstand this manipulation) for the benefit of the suffering patients.
vg_future
abew4me, thanks for the post and thoughts. Makes sense.
-vg_future
Lima4918, as per the standard ways of working and previous statements from Anavex, data will be released as soon as they receive it. So, his answer/response is well along those lines. He cannot and will not say if he has seen the data and has an idea about them. I bet he knows what they are. He will release them soon....as someone here mentioned...imminent.
-vg_future
Very well said and put Biostockclub. Appreciate your post and analysis.
-vg_future
Thanks for the notes TempePhil.
-vg_future
Wait for Anavex and Dr.Missling to provide the accurate info. Rest is all just opinions.
-vg_future
I would wait for Anavex's official release about PDD data and the
end points. Anavex knows what the results are, how powerful they are and who are all they are discussing those with for partnership or otherwise. This makes it even more important that we wait for the official word from the company.
-vg_future
raja48185, here is a surprising and funny thing. If the other poster has called that AVXL will go down (or has been bashing it)....why should he complain today...he (and all the others who were saying that it will go down) should be happy, right? Something isn't right in their conviction or they are here just BSing.
Hope Anavex gives them a good reason to cry and complain by moving really high.
JMHO,
vg_future
abew4me, agreed. RETT results will definitely prove the efficacy of Anavex's drug. This time, I am hoping for a surprise release of the read out to get the well deserved appreciation of the price. The treatment itself will be a great relief for many patients, but the price appreciation will ensure many more wonder drugs from Anavex.
-vg_future
nidan7500
AVXL is not going to miss, that is my bet. BTW, IMO they most likely already know that.
nidan7500, I would wait for the company to tell us if they missed end point...not some message board opinion. We have heard enough of this conjecture and endless repetition. It doesn't make it right...everyone is entitled to their own set of opinions, but not facts. Data presented at CTAD is AZ relevant....period....what is PDD related will be done later. Why the company chose to do that way, we can only opine. But, I would trust the company to take the best decision based on the data and strategic timing and moves.
-vg_future
MJFF webinar Nov 19th There was one webinar today (more about foundation work I think) and there is one on 19th (this seems more relevant because it is going to touch upcoming trials....see the snippet from the below link
https://www.michaeljfox.org/webinar/whats-next-parkinsons-big-trials-new-treatments-and-steps-toward-prevention
Hear the latest news in Parkinson's research from Foundation and field leaders. Our panelists will look ahead to treatments up for approval soon, new trials starting early next year and a major expansion of our landmark PPMI study to enable preventive therapies. We'll also discuss initiatives to better understand Parkinson's genetics across populations. Panelists and MJFF staff will answer questions from the audience throughout the hour
-vg_future
Good question nidan7500. So, nothing about any (other) company or trials...so, why we should be wondering or be surprised about not seeing Anavex mention.
-vg_future
Then we will have a December to remember...still before Christmas
Yep. A November to remember. Catchy.
I wish we took off by now with CTAD....to can the option manipulators.
-vg_future
Thanks TTTav66. Here is the strange thing...GWPH went up by $2 today in spite of discontinuing the study (of course genuine reasons) whereas our stock stock continues to be beaten up everytime it releases good/great NEWS. Hope this treatment (of the stock I meant) changes soon.
Wishing the best to the RETT community which is badly in need of cure/solution.
-vg_future
To be clear. GWPH makes money on other products that got approved. So, RETT is just one of the many indications that they are pursuing.
Looking at the volume...we might be making a considerable move today. The job posting information and all other possibilities are bringing the right focus and much needed appreciation today and this week.
JMHO,
vg_future
We never know...what if the new job opening opens the flood gates that should have opened when partial PDD results were presented at CTAD. Who knows if the entire results are going to be published this week. Other key PRs are also a possibility. Bottom line, hard to say when so many things are in the works.
-vg_future
Yes. We shall find out soon. As Raja's friend mentioned/opined, this means that big things are about to be kicked off....soon.
-vg_future
It seems like a pretty big amount to be committed unless there is an approval, or a very strong indication of approval. we shall find out soon.
-vg_future
Just FYI, they publish even if they go through a qualified head hunter. Companies still use LinkedIn, Indeed, and other Professional job sites and also their own websites.....all these in addition to a Head Hunter. They don't have to be secretive about this. For Anavex, this is a critical post, but not a CEO, CFO, COO or CTO level job that they have to be secretive.
Take the positive NEWS and the possibility of a good NEWS and be happy.
I see some here are getting restless due to Anavex's bright future.
-vg_future
Welcome aboard. Really appreciate the updates that you have afforded on stocktwit board.
-vg_future
tootalljones, thanks for the update from stocktwits. Looks like we are very close to the BIG ONE . I see some guys here trying to cast some doubt on PDD readout...but, Anavex would soon put a cork on this noise. Awaiting read outs and the details eagerly....
-vg_future
nidan7500, anything is possible particularly if the results are stellar and need FDA attention for special approval or otherwise. Having said that, many biotech companies present/publish the data (atleast high level summary) and then go to the FDA.
-vg_future
Powerwalker, thanks for the clarification on the earnings report. Fingers crossed and waiting for the read outs.
-vg_future
Jonjones325, exactly. CTAD was AZ conference and hence relevant data was presented and most probably as ALLOWED (my assumption). I am really really waiting for Anavex to uncover the remaining data points and shed the light on the success of the trials and the great potential. Regarding earnings, I am hoping they come out sooner than December (last one was on Aug 6th and it has been 3 months since then and the fiscal quarter ended in Sep, 2020). Exciting times.
I appreciate your updates from BBB.
-vg_future
Jonjones325, thanks for the info. I think Anavex will soon schedule a conference to showcase the whole enchilada and blow away the nay-sayers once for all. Next week is big opportunity considering the Parkinson conference this coming week (George posted the link for the conference ..... Parkinson Conference 2020 on Nov 16th nd 17th).
-vg_future
Just as a reminder (not that anyone needs one), last week's presentation was AZ relevant data from PDD studies. Anavex presented what they can and have to at CTAD. So, talking about endpoints is just that....an opinion at best. I would wait for the company and FDA (through their guidance and/or decisions) to speak and vouch for end points.
-vg_future
Well articulated.
-vg_future
Good analysis ...if this hasn't been posted here yet
https://insiderfinancial.com/will-biogen-now-buy-anavex-life-sciences/180656/?fbclid=IwAR3ClRzfBjs9TsCdPyOEaoP1KhFWzAXm3u3sjBXV17S58J-wV1g8wBkINZE